Drug
Loxapine
Loxapine is a pharmaceutical drug with 6 clinical trials. Historical success rate of 50.0%.
Total Trials
6
Max Phase
—
Type
DRUG
Molecule
—
Success Metrics
Clinical Success Rate
50.0%
Based on 3 completed trials
Completion Rate
50%(3/6)
Active Trials
0(0%)
Results Posted
33%(1 trials)
Terminated
3(50%)
Phase Distribution
Ph phase_3
1
17%
Ph not_applicable
1
17%
Ph phase_4
2
33%
Ph phase_2
1
17%
Phase Distribution
0
Early Stage
1
Mid Stage
3
Late Stage
Phase Distribution5 total trials
Phase 2Efficacy & side effects
1(20.0%)
Phase 3Large-scale testing
1(20.0%)
Phase 4Post-market surveillance
2(40.0%)
N/ANon-phased studies
1(20.0%)
Highest Phase Reached
Phase 4Trial Status & Enrollment
Completion Rate
50.0%
3 of 6 finished
Non-Completion Rate
50.0%
3 ended early
Currently Active
0
trials recruiting
Total Trials
6
all time
Status Distribution
Completed(3)
Terminated(3)
Detailed Status
Terminated3
Completed3
Development Timeline
Analytics
Development Status
Total Trials
6
Active
0
Success Rate
50.0%
Most Advanced
Phase 4
Trials by Phase
Phase 21 (20.0%)
Phase 31 (20.0%)
Phase 42 (40.0%)
N/A1 (20.0%)
Trials by Status
terminated350%
completed350%
Recent Activity
0 active trials
Showing 5 of 6
terminatedphase_2
Tolerability and Analgesic Efficacy of Loxapine in Patients With Refractory, Chemotherapy-induced Neuropathic Pain
NCT02820519
completed
Family Intervention in Recent Onset Schizophrenia Treatment (FIRST)
NCT02600741
terminatedphase_4
Inhaled Loxapine vs Intramuscular (IM) Haloperidol + Lorazepam for Agitation
NCT03110900
terminatedphase_3
Randomized Double-blind Trial of Midazolam and Loxapine in Agitated Patients
NCT00290082
completedphase_4
Loxapine in the Management of Restlessness During Mechanical Ventilation Weaning
NCT01193816
Clinical Trials (6)
Showing 6 of 6 trials
NCT02820519Phase 2
Tolerability and Analgesic Efficacy of Loxapine in Patients With Refractory, Chemotherapy-induced Neuropathic Pain
NCT02600741
Family Intervention in Recent Onset Schizophrenia Treatment (FIRST)
NCT03110900Phase 4
Inhaled Loxapine vs Intramuscular (IM) Haloperidol + Lorazepam for Agitation
NCT00290082Phase 3
Randomized Double-blind Trial of Midazolam and Loxapine in Agitated Patients
NCT01193816Phase 4
Loxapine in the Management of Restlessness During Mechanical Ventilation Weaning
NCT00122733Not Applicable
Loxapine and Weaning From Ventilator
All 6 trials loaded
Drug Details
- Intervention Type
- DRUG
- Total Trials
- 6